MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 139 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $153,000 | -26.8% | 2,135 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $209,000 | -53.0% | 2,135 | -59.4% | 0.00% | -50.0% |
Q4 2021 | $445,000 | +5.5% | 5,255 | 0.0% | 0.00% | +33.3% |
Q3 2021 | $422,000 | -17.6% | 5,255 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $512,000 | -16.7% | 5,255 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $615,000 | +5.3% | 5,255 | 0.0% | 0.01% | -50.0% |
Q4 2020 | $584,000 | -35.8% | 5,255 | -31.4% | 0.01% | -42.9% |
Q3 2020 | $909,000 | +4.8% | 7,655 | 0.0% | 0.02% | -19.2% |
Q2 2020 | $867,000 | +69.7% | 7,655 | 0.0% | 0.03% | +8.3% |
Q1 2020 | $511,000 | -24.7% | 7,655 | +2.7% | 0.02% | +26.3% |
Q4 2019 | $679,000 | +4.8% | 7,452 | 0.0% | 0.02% | -24.0% |
Q3 2019 | $648,000 | -16.1% | 7,452 | +1.1% | 0.02% | -21.9% |
Q2 2019 | $772,000 | -12.1% | 7,369 | +5.1% | 0.03% | -20.0% |
Q1 2019 | $878,000 | +64.7% | 7,013 | +48.4% | 0.04% | +73.9% |
Q4 2018 | $533,000 | -47.5% | 4,727 | -0.3% | 0.02% | -57.4% |
Q3 2018 | $1,015,000 | – | 4,740 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |